“The UK has now banned puberty blockers—probably will ban cross-sex hormones too, is my prediction, in the next few years,” said Leor Sapir, a fellow at the Manhattan Institute.
He has been following the massive increase in children identifying as transgender and undergoing what’s known as “gender-affirming care” treatment—from puberty blockers to double mastectomies.
“WPATH [The World Professional Association for Transgender Health] commissioned systematic evidence reviews as part of the process of developing [Standards of Care Version 8]. When it found out that the evidence reviews, specifically for minors, were unimpressive and did not get them the results that they wanted—that would support their medical approach, they suppressed them. They basically instructed the researchers at Johns Hopkins University who were doing these systematic reviews to not publish them,” said Sapir. “Any way you look at it, WPATH greatly deviated from how responsible, trustworthy medical guidelines are supposed to be developed.”
“HHS needs to deprogram itself from gender ideology. It needs to get rid of all the ideological language, all the directives the NIH for example, needs to stop pumping money, hundreds of millions of taxpayer dollars into research whose only purpose is to promote these interventions, I actually think that instead of cutting off, instead of shutting off the valve, NIH should reorient itself and devote money to studying the harms which are not studied. Nobody's studying harms because the gender clinicians doing the research don't want to know they're only studying benefits, and then they're spinning the results of their studies. We need evidence on detransition and regret, which are real and growing phenomena.”
“We need the federal government to use its powers to investigate how the American medical profession went off track here and what can be done to restore us to a place of evidence based ethical medicine.”
CHAPTER TITLES 0:00:00 - Introduction to the Topic 0:01:02 - Luo Sapir's Background and Expertise 0:04:20 - Lack of Consensus Among Medical Associations 0:07:41 - The Alabama Case and WPATH's Suppressed Evidence 0:15:33 - Europe's Systematic Approach to Evidence Review 0:18:17 - Explanation of Gender Affirming Care Approach 0:20:00 - Recommendations for the Incoming Administration
Leor Sapir about the absence of credible evidence in favor of transitioning: “These interventions, including social transition in school, are said to be based on credible science, credible research over the years, and there just isn't that kind of evidence to support it. And I found it fascinating that you have this, you know, consensus has formed around these types of interventions, psychological as well as physical. In the absence of any credible evidence, school personnel and advocacy organizations believe, sometimes sincerely, that they are just following the best practices as announced by the medical community.”
“Last year, the American Society of Plastic Surgeons broke with the consensus and said we recognize that there's really no good evidence for this in minors.”
Sapir explains how a pseudo consensus on transitioning developed: “If you actually look at how these treatments ascended to the level of a consensus among medical associations, first of all, these are professional trade unions. It's important to recognize that they exist to protect doctors and promote the interests of doctors… The American Academy of Pediatrics, for example, about a decade ago, convened a special working sub group on LGBTQ health and appointed, I think it was six clinicians to that subgroup who were all kind of ideologically on board with gender transition treatments for kids, and the rest of the leadership of the AAP deferred to their colleagues in the specialized Subcommittee on the assumption that they know what they're talking about.”
Why age minimums were eliminated for transitioning drugs and surgeries: “They said, we're now eliminating all age minimums for medical interventions for kids, with the exception of phalloplasty, right? So all surgeries, all hormones, puberty blockers, all none of that have any age minimums from now on. And it turns out that they did that, not for any clinical reason or because of evidence, but they did that under pressure from Dr Rachel Levin, who was the Assistant Secretary for Health in the Biden administration.”
🔵 Sign up for the American Thought Leaders ALERTS newsletter to stay up-to-date on new episodes, releases, and special events 👉 https://ept.ms/ATLnewsletter
The UK has now banned puberty blockers.
Probably will ban cross-sex hormones, too,
is my prediction in the next few years.
Lear Sapir is a fellow at the Manhattan Institute,
where he's been following the massive increase in children
identifying as transgender and undergoing
what's known as gender-affirming care treatment,
from puberty blockers to double mastectomies.
Any way you look at it, WPATH greatly
deviated from how responsible, trustworthy medical guidelines
are supposed to be developed.
And they suppressed this information
and tried to conceal it from the public.
His current area of focus is the pushback
to gender interventions for minors,
including state bans, lawsuits, and the landmark case
now at the Supreme Court.
This case has tremendous consequences
for what's going to happen in the 26 states that have banned
these interventions in minors.
This is American Thought Leaders,
and I'm Jan Jekielek.
Lear Sapir, such a pleasure to have you
on American Thought Leaders.
Thanks for having me.
Tennessee has banned what's dubbed
gender-affirming care type treatment for children
experiencing gender distress.
This is in front of the Supreme Court right now.
With this new Trump DOJ coming in,
they could just walk away from this case
and let that Tennessee law stand.
You're arguing against that, though.
Explain that to me, please.
That's right.
So the Trump DOJ could, in theory,
let this case, or I should say back away from the case,
drop it.
And I argue that they shouldn't do that.
I think the facts of the case, and more importantly,
the arguments of the case, are heavily
on the side of Tennessee.
And the court, being a conservative majority court,
is likely, some would argue almost certain,
to rule in favor of Tennessee.
And this case has tremendous consequences
for what's going to happen in the 26 states that have banned
these interventions in minors.
Before I get you to talk about the evidence,
maybe tell me a little bit how you've
come into being an expert on this question.
I stumbled into it, frankly.
I wrote a dissertation on Title IX,
the federal law that prohibits discrimination
on the basis of sex in education.
And I wrote on how the Obama administration
and the federal courts had changed
the meaning of Title IX to require schools
to defer to students according to their gender identity,
the way in which they self-defined, self-identified
as male or female.
And what I started to notice, actually,
during my postdoc year, is that the arguments being
made by advocacy groups like the ACLU were medical.
These were medical arguments citing
medical professionals, medical associations,
and medical literature.
And so I started looking at that literature.
And once you look, you can't look away.
Because the reality of the situation
is that these interventions, including
social transition in school, are said
to be based on credible science, credible research
over the years.
And there just isn't that kind of evidence to support it.
And I found it fascinating that you
have this consensus has formed around these types
of interventions, psychological as well as physical.
In the absence of any credible evidence,
school personnel and advocacy organizations
believe, sometimes sincerely, that they are just
following the best practices as announced
by the medical community.
It can be very difficult for people
to believe that a whole, that the entire medical community,
or maybe not the entire, but the decision makers
in the medical community have adopted something
that you're suggesting actually doesn't have a basis
in medical evidence.
That's right.
And that's usually the first hang up
when you talk to people who know maybe a little bit
about this topic.
They'll say something like, look,
this is the consensus of medical authorities.
And by medical authorities, they mean
professional medical associations,
the American Medical Association,
the American Academy of Pediatrics,
the Endocrine Society, and so on and so forth.
So I think a few things here need to be said.
First of all, if the standard is consensus
of medical associations or medical bodies,
there is no consensus even by that standard
because numerous European countries,
health authorities in several European countries,
after conducting systematic reviews of evidence
have backed away from these treatments,
recognizing that, in fact,
they lack credible evidence of benefits.
And they have a real potential to do harm.
So there's no consensus regardless.
Even if you look only at the United States,
the medical associations don't all march
in lockstep on this issue.
For example, last year,
the American Society of Plastic Surgeons
broke with the consensus and said,
we recognize that there's really no good evidence
for this in minors.
But the more important point, of course,
is that consensus-based medicine
is not the same as evidence-based medicine.
That is a very important distinction.
And in fact, the field of evidence-based medicine,
which came into its own during the 1990s,
was created precisely in order to create this distinction
between what doctors say is good treatment
and what the evidence actually supports.
And so you have to recognize,
you have to acknowledge that, yes,
there is a kind of a pseudo-consensus,
and I'll say it a minute while it's a pseudo-consensus,
but that doesn't mean
that these are evidence-based treatments.
That just means that medical groups say they are.
To take that one step further,
if you actually look at how these treatments
ascended to the level of a consensus
among medical associations,
first of all, these are professional trade unions.
It's important to recognize that.
They exist to protect doctors
and promote the interests of doctors, first and foremost.
But more importantly in this case,
they have oftentimes subcommittees
that specialize in a certain area of care.
So the American Academy of Pediatrics, for example,
about a decade ago,
convened a special working subgroup on LGBTQ health,
and appointed, I think it was six clinicians
to that subgroup,
who were all kind of ideologically on board
with gender transition treatments for kids.
And the rest of the leadership of the AAP
deferred to their colleagues in the specialized subcommittee
on the assumption that they know what they're talking about,
they're the experts in the field, and what do we know?
And what you see, Jan,
is that in a field as advanced
in terms of scientific knowledge as medicine,
where there is high levels of complexity
and division of labor,
you have to have that
in order for these types of human endeavors to be possible.
There's a great deal of trust and deference
between medical professionals.
And that trust can be exploited and has been exploited.
So that's kind of the backstory
to how we got to the pseudo consensus.
You had the leadership of these medical associations said,
look, we're not experts, but these people claim they are,
so we're just gonna defer to them.
There was a recent lawsuit in Alabama
that in the process of discovery,
they basically put into the discovery.
As far as I'm aware,
that is the most detailed compendium,
up-to-date compendium of evidence that I'm aware of.
And maybe you can speak to it.
Sure, I mean, in a way it's unfortunate
that the case before the Supreme Court is the Tennessee ban.
And one of the reasons the Biden administration
decided to appeal that ban
is precisely because the evidence record in that case
is incomplete.
The Alabama case has by far
the most complete evidence record.
And so that's, there's a good reason
that the Biden administration
decided not to appeal from there.
But look, I've said this before,
and I continue to believe it.
I think the greatest mistake the gender industry
in the United States ever made
was to sue the state of Alabama
over its ban on youth transition.
What happened is that the attorney general
of the state of Alabama secured subpoenas
from the judge in that case, Judge Lyle Burke,
to have the World Professional Association
for Transgender Health,
whose Standards of Care Version 8
control the entire medical field in this area
in the United States,
to subpoena all their internal emails
related to the development of Standards of Care 8, SOC 8.
And what those emails have revealed
has been nothing short of shocking.
Those emails contain the smoking gun evidence
of medical scandal.
And so here's kind of in a nutshell what they found.
WPATH commissioned systematic evidence reviews
as part of the process of developing SOC 8.
When it found out that the evidence reviews
specifically for minors were unimpressive,
did not get them the results that they wanted,
that would support their medical approach,
they suppressed them.
They basically instructed the researchers
at Johns Hopkins University
who were doing these systematic reviews
to not publish them.
And then they also claimed in SOC 8,
they said systematic review of evidence for minors
is not possible,
even though they themselves had commissioned one
and suppressed it.
More than that,
they also spoke to what they called in internal emails,
a social justice lawyer.
And that lawyer told them,
according to these emails,
that having these types of systematic reviews
would actually be bad for WPATH
since it would compromise its ability to win lawsuits.
And it would also place clinicians
who provide these treatments
at legal risk for malpractice.
So it killed the evidence reviews
and claimed that they're not possible.
Beyond that, WPATH also,
in a move that surprised a lot of us,
a few days after it published SOC 8 in 2022,
it issued a correction in the medical journal
in which SOC 8 came out.
And it said,
we're now eliminating all age minimums
for medical interventions for kids
with the exception of phalloplasty, right?
So all surgeries, all hormones, puberty blockers,
all, none of that have any age minimums from now on.
And it turns out that they did that
not for any clinical reason or because of evidence,
but they did that under pressure from Dr. Rachel Levin,
who is the Assistant Secretary for Health
in the Biden administration,
who expressed concern that having age minimums,
specified age minimums in SOC 8
would draw political controversy.
And it turns out the American Academy of Pediatrics,
which told WPATH, we're not going to endorse this.
In fact, we're gonna actively oppose it
if you specify age minimums,
so you've got to get rid of them.
And we have other things
that have come out of that discovery
that are no less concerning.
For example, the lead author of SOC 8
admitted in a deposition in this case
that conflicts of interest,
both financial and intellectual conflicts of interest,
were simply overlooked in the process
of recruiting people to work on SOC 8.
In fact, having a conflict of interest
was deemed to be a prerequisite
to being on the SOC 8 committee,
which is really shocking.
It violates every tenet
of how responsible guidelines should be developed.
Just clarify that for me.
It didn't say having a conflict of interest
was a prerequisite, what do you mean?
Right, so what happened was,
this came out of the deposition of Eli Coleman,
who's the lead author of SOC 8,
and also of Marcy Bowers,
who was then the president of WPATH
and also a co-author on SOC 8.
Coleman was asked explicitly,
were you aware that most of the people
on the SOC 8 development committee
had conflicts of interest?
And he said yes, he was aware.
And yet, if you look at the disclosure section,
it says no conflicts of interest.
Marcy Bowers said that being a proponent
of the medical gender-affirming approach
was a prerequisite to being invited
to participate on the committee.
So the WPATH leadership has admitted this
under oath in the deposition.
What do I mean by financial
and intellectual conflicts of interest?
A few of the developers of SOC 8
were expert witnesses in cases
in which what SOC 8 would have said
would determine whether their side
in the lawsuit ends up winning.
So they stand to gain financially
from SOC 8 saying certain things and not others.
Marcy Bowers, the president of WPATH,
said in a deposition,
admitted to making over a million dollars in 2023
from performing gender surgeries.
Most of the other clinicians
on the SOC 8 development team also made money,
had professional appointments,
gained professional reputations
from performing these procedures
or at least endorsing them.
And those are considered financial conflicts of interest.
And of course, intellectual conflicts of interest,
if you become a public advocate,
if you write in favor of a certain position,
you're less likely to evaluate impartially
the evidence base for a treatment.
So the key thing here is that
the U.S. Institute of Medicine in 2011
announced standards for the development
of what they called trustworthy medical guidelines.
And WPATH claimed that they were following these standards.
In fact, Eli Coleman himself claimed
that those standards were controlling.
But if you look at those standards,
they clearly and explicitly say
you cannot have people with conflicts of interest
dominating the process of developing a medical guideline.
Any way you look at it, WPATH greatly deviated
from how responsible, trustworthy medical guidelines
are supposed to be developed.
And they suppressed this information
and tried to conceal it from the public.
WPATH basically is the standard
that a lot of these professional organizations
have followed, right?
But WPATH isn't per se a medical organization
as I understand it.
So how did WPATH rise to prominence?
You know, I mean, it's a situation, again,
in which you have a specialized group
of clinicians and activists.
And it's true that WPATH is,
even though it calls itself
the Professional Association for Transgender Health,
it's an activist group made up of lots of,
you know, disparate elements.
Not all of them are doctors,
not all of them are mental health professionals.
Some of them are journalists,
run-of-the-mill activists,
some of them are social workers.
But they have positioned themselves as the experts.
And, you know, nobody really questions that
in the medical field,
although now they do.
And certainly in Europe,
European countries completely reject WPATH.
I think the director of Belgium's
Center for Evidence-Based Medicine said
he would throw WPATH's guidelines in the dustbin.
So there are no fans of WPATH there.
But here in the United States,
they are de facto the authorities in the field.
In the absence of other organizations issuing guidelines,
and there's one exception,
the Endocrine Society did issue a guideline.
But in the absence of other organizations saying,
no, we're gonna issue our own guideline
and take a different approach,
WPATH has emerged as the de facto leader in the field.
WPATH did not immediately respond
to a request for comment.
So, and how is it that Europe has taken,
in, you know, writ large, right,
has taken, you know,
really looked more systematically at the evidence?
How do you explain that exactly?
You know, it's a great question,
and it's one that concerns me a lot.
So first of all, just to, you know,
so listeners are aware,
the UK has now banned puberty blockers.
Probably will ban cross-sex hormones too,
is my prediction in the next few years.
Surgeries are almost never performed
outside the United States, extremely rare.
Lior, before you continue,
maybe just lay out to me what this gender,
as quickly as possible,
what this gender-affirming care approach is,
because you mentioned a few elements of it,
but I'd just like to offer a picture.
So according to kind of the, you know,
the standard protocol as developed in the Netherlands,
as soon as a kid reaches Tanner stage two of puberty,
which is kind of the early development of puberty,
the first stage is puberty blockers,
which, as the name implies,
block puberty from going into effect.
Initially, these drugs were intended to
kind of provide a window of time for kids
to figure out whether to continue with transition.
Now we know, based on research,
based on the expertise of clinicians involved in the field,
that that is simply not the case,
because almost 100% of kids who go on puberty blockers
end up going on to cross-sex hormones.
So blockers very likely lock in the gender distress
that would otherwise, in most cases,
you know, evaporate as the kid goes through puberty.
So the first step has gender distress,
not sure, you know, whether they're male, female,
or something else.
Yeah.
And then the next step is?
Well, I mean, according to the traditional protocol,
they had to be quite sure that they are,
in fact, the opposite sex.
And so they would be given puberty blockers to figure out,
time to figure it out.
And almost all of them would, of course,
figure out that, in fact, they're trans,
they want to proceed.
And so the next step is cross-sex hormones.
So testosterone if you're a boy,
if you're a girl, estrogen if you're a boy.
And whereas puberty blockers prevent the body
from developing through its endogenous puberty process,
cross-sex hormones are meant to induce the appearance
of sex characteristics that mimic the opposite sex.
So, you know, in girls who take testosterone, for example,
their voice will get lowered,
and that could actually be irreversible.
And then the final stage,
in the United States, at least, surgeries.
And for boys, this is much, much more rare,
but for boys, it could involve a vaginoplasty,
a surgical inversion of the penis,
or if they went on puberty blockers
and their penile tissue didn't develop,
the surgeon will borrow tissue from the colon
and create kind of a semblance of a vagina
with the colon tissue.
In Europe, these surgeries are usually only offered
after age 18, but in the United States,
they are offered to minors as well.
So that's the full protocol.
Now, you know, there's deviations from it.
Some kids only want, in the United States,
gender-affirming care is typically more a la carte.
It's whatever the kid wants, right?
So if they want just the cross-sex hormones,
that's what they get.
If they want just the surgery, that's what they get.
And now, also within the last five, six years,
we've seen the rise of so-called non-binary procedures,
which unlike the Dutch protocol,
the non-binary procedures are really just meant
to allow kids to pursue whatever,
as the clinicians call it, embodiment goals they want.
So if they want, you know, a little bit of body hair
and to also have breasts and all that kind of stuff,
they can kind of mix and match their drugs and surgeries
to produce idiosyncratic body types
that are not found in nature.
So in Europe, you were starting to say,
when I stopped you, and in the UK,
they banned puberty plockers.
So that basically stops this whole process.
The UK and Finland and Sweden have recognized,
based on systematic evidence reviews,
that these treatments are fundamentally still experimental.
You know, Norway has significantly scaled back.
Denmark has significantly scaled back.
Medical authorities in Germany and France
have issued stern warnings about these procedures in Italy.
Why is it that these countries have managed to do this,
whereas in the United States, you know,
things have gone totally off the rail
and there seems to be, other than kind of political pushback
through Republicans, there seems to be nothing to stop it?
It's a complicated question.
I think a large part of the answer has to do
with how our health system works
compared to their health system.
So in Finland, for example, or Sweden,
these are government-run health systems.
So the government pays for insurance,
but also runs the hospitals.
And what happens there is that government
has a fiduciary responsibility to taxpayers
to use finite resources in a responsible way
to promote the health of the public.
And that means that they have a strong incentive
to make sure that they're allocating resources
to treatments that are really evidence-based,
that are effective.
And so these countries have agencies.
In Finland, it's called
the Council for Choices on Healthcare.
In Sweden, it's the SBU.
In the UK, it's the National Institute
for Health and Care Excellence.
These are agencies, government agencies or public agencies
that have the responsibility to evaluate impartially
the evidence base for medical treatments.
And every single agency in Europe that has done that
has come to the exact same conclusion.
There is no credible evidence
that these treatments are safe and effective.
In the United States, things are very different.
We don't have universal government insurance,
and we have private insurance companies
that can recoup their costs.
So if Blue Cross or UnitedHealthcare or whatever
pays for these interventions,
they can just raise premiums across the board
and recoup their costs without considerations
of fiduciary obligation to taxpayers.
More than that, because we as Americans
have a kind of a healthy distrust of centralized power
and centralized government,
medical policymaking is de facto done in the States.
And even more de facto is controlled heavily
by medical boards and professional medical associations,
who are, as I said earlier, essentially trade unions,
that advocate on behalf of doctors and doctor interests.
And so we have plenty of examples
throughout American medical history
of medical associations learning that the evidence
doesn't support a certain treatment
that their members perform and make money from,
and yet opposing any efforts to impose restrictions.
Good example is arthroscopic knee surgery,
where a double-blinded randomized control trial
found that in the vast majority of people who get them,
over half a million people get them every year,
they're no better than what's called a sham surgery,
meaning a placebo surgery.
So CMS wanted to cut off a lot of these surgeries,
and the association that is essentially the home of surgeons
who perform these procedures,
they said, no, sorry, we don't accept the findings
of this systematic review,
please interpret it very narrowly
and don't issue any correction to current practices.
So that's just one example, and there's many I could give,
but the bottom line is we have this kind of
highly decentralized healthcare system
where the financial interests and professional interests
of doctors, of medical associations, of drug companies
have a very heavy role.
Now, I should mention one last thing,
which is we do, in fact, have agencies
that are counterparts to the ones I mentioned in Europe.
We have PCORI,
the Patient-Centered Outcomes Research Institute.
We have AHRQ, which sits within the HHS government department
and these are agencies tasked with assessing
the evidence base for medical interventions.
The problem is that in the wake of the Affordable Care Act
being passed in 2010, Republicans neutered them.
Republicans went to war with these agencies
and basically said, in cooperation
with medical associations and drug companies,
and basically said, we don't want these government agencies
or publicly funded agencies
to dictate healthcare decisions.
And probably not expecting this as an outcome.
Yeah, I mean, it's a good example
of the unintended consequences of policy decisions.
Another very systematic, detailed review of the evidence
was this Cass Review in the UK,
which led to this outcome that you described.
That's right.
If someone is interested in understanding
sort of the body of actual evidence
around these types of procedures,
where's the best place someone can go
to kind of dig deep a little bit and understand that?
Well, the Cass Review is not a systematic review per se.
It's a almost 400-page report
based on a multi-year investigation
of the UK's Gender Identity Development Service,
which has since been discontinued,
but it's based on seven new systematic reviews
of evidence and guideline quality
that were commissioned for the purpose
of the review itself.
And so there have been,
a number of these systematic reviews have appeared.
In the UK, a few were done in Sweden and Finland.
One was done by McMaster University in Canada,
which is the home of evidence-based medicine,
commissioned by a Florida healthcare agency.
Is there one place where all of this appears?
I'm not sure.
You kind of have to look for it.
You have to know what you're looking for.
The Cass Review is a good place to start.
It's a very long document.
Unfortunately, it's written
in the language of gender ideology.
I think that was intentional to get buy-in
from kind of people on the other side of this issue,
but it does discuss the evidence, the ethical problems,
what we know, what we don't know,
the clinical practices that have come into being
in the last decade or so,
and it creates a pretty damning picture.
It's proven to be hugely transformative in this field.
It has made it impossible for American medical groups
and gender clinicians to continue pretending
that anybody who disagrees with their radical approach
is an ideologue who hates people
who identify as transgender.
I don't think anybody can take
that argument seriously anymore.
Well, and so let's actually build
on that a little bit here, right?
There's been this huge issue in the last few years
about parental rights,
that parents should ultimately decide,
but what if parents decide
that this is a good course of treatment?
Yeah. Right?
Yeah, so I mean, that does present a certain dilemma
because those of us who have been trying
to push back against this medical scandal and expose it,
in the context of education in schools,
we've been making arguments about parental rights.
Schools should not perform social gender transition
on kids behind parents' backs.
There are serious consequences to that.
Parents should be involved.
Parents have a right to know, to decide.
But in the medical context,
those who advocate for the gender-affirming care pathway
are the ones claiming parental rights.
They say states should not ban it.
Let parents make the decision.
These decisions should be between parents
on behalf of their kids and doctors.
Here's why I think that's wrong.
I think it's wrong for a number of reasons.
First of all, parents don't have a right
to dictate medical treatment.
They have a right to choose from among the treatments
that doctors can responsibly and ethically offer to them.
The doctors have the primary responsibility
to only offer treatments that are within the standard
of care, that are evidence-based,
and that are net beneficial,
or at least reasonably assumed to be.
So medicine is not consumerism.
It's not as though a parent can walk into a clinic
and just pick and choose whatever they want.
So the question of parental rights is, first of all,
I think the most important thing to say,
it's logically secondary to the question
of what doctors should be offering and why.
But beyond that, if you actually have seen
what happens in a gender clinic,
if you've seen the consent forms,
if you've spoken to people like Jamie Reed,
who have worked in these clinics,
and I know that you've interviewed Jamie,
parents are almost never given the full unvarnished picture
of what we know and what we don't know
about these interventions.
Sometimes they're given a very incomplete story.
Sometimes they're outright lied to.
For example, we have numerous examples
of parents being told by the gender clinician,
sometimes in front of their own kid,
that if the kid doesn't access these treatments,
he or she will kill herself.
There's no evidence that that's true.
And in fact, it's a dangerous thing for a clinician to say,
especially in front of a kid.
Under those circumstances,
what parent would not agree to these treatments?
If the alternative is death, any risk is worth it.
And then on top of that, we also see many of these cases
of parents disagreeing with each other.
It's almost always the mom who wants to do it
and the dad who is skeptical,
which I find that's pretty interesting.
I've spoken to journalists who have interviewed
many parents associated with particular clinics,
and they've said, yeah, that's pretty much
what we observe too, it's almost always the mom.
But regardless, what happens when the parents disagree?
So in Jamie Reed's clinic, the practice was,
you go at the parent who agrees,
and you lie to the parent who disagrees.
You just kind of, you get them out of the picture
as fast as you possibly can.
I remember watching a training session,
I think it was at the Cleveland Clinic,
where the gender clinicians there said,
if the parents disagree, we just have to keep working
with them until they agree.
So even if you buy the parental rights argument
and ignore the more important responsibility
of clinicians not to offer these treatments
in the first place, parents are very often lied to,
misled, and bullied into submission
in order to agree to these interventions.
And once they agree, they cross a Rubicon.
Once you agree to medical interventions
that have irreversible consequences for your kids,
including sterility, possible sexual dysfunction,
cognitive impairment, it's very difficult for any parent
to say, actually, this was the wrong thing for me to do.
I harmed my kid.
And so that's why I've always been very sympathetic
to the parents who agree to these medical interventions.
I've always been very against activists
who are kind of pushing back against gender medicine,
who want to demonize parents,
who want to try to cast them
as abusers of their own children.
Because in the vast majority of cases,
these parents were lied to.
They were misled, they were bullied.
They don't deserve to be demonized twice.
They're suffering enough on account
of what happened to their kid.
So we need to be able to provide them with off-ramps
to recognize that this was not the right decision
and to figure out a way back to restore their kid's health.
There's always kind of a cost-benefit.
Is that how you think about it?
That you have to kind of look at it
from a cost-benefit perspective?
Yeah, I mean, so let's break this down
into kind of two buckets.
In one bucket, we have the question of clinical outcomes.
What do we know about the benefits and harms,
the benefits and risks of social transition
and medical intervention, medical transition?
And on both of those fronts,
I think so far the evidence quite clearly says
there's no credible basis to believe
that these are beneficial
and the risk of harm is real and substantial.
And so therefore, there's kind of a very compelling argument
to stave off these interventions as long as is possible
and let the kid mature, let them get psychotherapy,
let them figure things out.
Most of these kids, or at least a lot of them are gay
and will realize that about themselves.
So that's kind of one approach.
Let's call it the clinical outcomes approach.
The other approach is to question
the very conceptual basis of these interventions for kids.
What is it exactly that we're treating here and why?
If you give insulin to a kid,
it's probably because the kid has diabetes, right?
You can test for diabetes.
There's an objective test that is high on specificity,
meaning you're not gonna have false positives.
And you can know that you are giving them
a life-saving intervention
for an objectively diagnosable medical condition.
That doesn't exist here.
The basis for intervention is subjective.
It's a kid's feelings.
And feelings, of course, have multiple causes.
They're likely to change.
But more importantly than that,
the modern practice of gender medicine,
unlike 15, 20, 30 years ago,
rests on a series of pseudoscientific claims
about the human person.
That sex is assigned at birth,
meaning a social construct.
That's not true.
That all humans have an innate gender identity
that they can know from very early in life infallibly,
and that will never change,
although somehow it's also said to be fluid.
And that kids can know with absolute certainty.
That's what the AAP says.
No basis to believe such a thing.
That is pseudoscience.
That's not science.
And so if you look at these young kids
who are suffering on account of something,
and you say, oh yeah, this boy is really a girl
who has assigned the wrong sex at birth,
that's a completely different conceptual framework
from what existed 20, 30, 40 years ago
where transsexual was understood to be a biological man
who, for whatever reason, would feel more comfortable
going through life appearing as
and being seen by others as a woman.
Doesn't mean he really is a woman.
It just means he would feel more comfortable that way.
And so still there was a kind of a hold,
a grasp on biological reality,
and that hold has loosened to a great degree
in our medical profession today.
And so the conceptual basis of these interventions
is already highly dubious,
even before you get to the question of clinical outcomes.
So you're saying that even thinking cost-benefit
in this case is not actually useful.
We can say with reasonable certainty
that some of these kids may go on in adulthood
to experience severe distress,
and they will associate it with their bodies.
And some of them will say,
I started feeling this way as a kid, as a teenager, right?
I don't have a basis to doubt that.
Maybe some people do.
For me, that seems like a good starting point
for a conversation.
These cases are extremely rare.
They are often driven by unresolved struggles,
mental health problems.
They could be a result of a sexual paraphilia.
There's the concept of autogynephilia
that I think more and more Americans
are beginning to understand.
And some people with autogynephilia talk about it openly.
But-
Just very briefly.
Yeah, autogynephilia is erotic attraction
to the thought of oneself as a woman.
You're attracted to, as a man,
you're attracted to what you would be like as a woman.
And you want other people,
when other people see you as a woman,
or you think they see you as a woman,
that causes a kind of erotic feelings, right?
So if you set aside the conceptual framework,
and you're looking at from a clinical outcomes perspective,
I think you can say, reasonably,
the vast majority of these kids
will come to terms with their sex,
and will realize that their problems are best resolved
not through dangerous drugs and surgeries.
A few of them might come to that conclusion
that nothing else will help them in adulthood.
We have no way to know who these kids are.
No way.
And clinicians, mental health professionals,
who say we're very cautious and conservative,
and we do extensive mental health assessments,
are deluding themselves.
There is no mental health assessment that will tell you this
because that kind of clarity about your identity,
relative clarity,
is the consequence of going through puberty,
is a consequence of reaching mature adulthood.
And so there really is no way for clinicians
to be able to say,
you are going to be a future transsexual,
and you are not.
And given the absolute moral hazard here,
and the potential to hurt so many kids irreparably,
I think by far the safest course of action
is to not do it in kids.
And even I, increasingly of the view,
even young adults, the 18 to 25 cohort,
I think we have research showing
that the brain doesn't stop maturing until around age 25.
Especially with this generation,
kids are growing up immature.
They're taking longer to reach that point
where they can make rational decisions.
And so I think there's a good case also
to restrict it in young adults.
Because the argument you hear,
and I think you've spoken eloquently about this,
the argument that you hear is
if they're not able to realize their true selves early enough,
there will be great suffering later in life, right?
Yeah, I mean, so that was the original justification
for the Dutch approach.
And they were the pioneers
just for the benefit of the audience of this whole thing.
That's right, the Dutch were the pioneers.
They observed, based on their clinical experience,
that the adults, adult transsexual men,
men who identified as women,
said that they were subjectively satisfied.
But if you actually look at their objective life metrics,
their psychosocial adjustments,
their ability to have relationships,
hold down jobs, function in life,
they were not doing well.
And so the theory was, the hypothesis was,
they're not doing well because they don't pass as women.
And if they pass as women,
then all these other problems would go away.
The effects of testosterone on male puberty are irreversible.
It's extremely difficult for a man
who goes through endogenous puberty to pass as a woman.
And so the theory was, let's bypass puberty
in order for these kids
to be able to pass later on as adults, as women.
If they pass as adults, pass as women,
they'll have a happier life.
They'll be better adjusted.
And also, they will be prevented from developing
what the Dutch thought were psychopathology
that resulted on account of going through the,
quote unquote, wrong puberty.
And so that was kind of the original hypothesis
that launched this medical experiment in the first place.
It is true that for some adults, especially men,
who are unable to pass as women,
that's agonizing for them.
It doesn't follow that we should be
bypassing the puberty of kids,
subjecting them to medical experiments
and chopping off healthy body parts.
Not every problem has an obvious technological solution,
certainly not one that doesn't carry moral risks
that make the intervention really scandalous,
as it does in this case.
Essentially, you're in favor
for banning this whole approach entirely,
because there's some arguments that would say,
well, maybe just a little bit of it.
Yeah, in kids, you mean, yeah.
Would be okay, right, right, right, exactly.
Yeah, I mean, so it's interesting.
You're starting to see some gender clinicians
and advocates of medical transition
agree that things have gone off the rail,
that the massive exponential rise
in the number of kids identifying as trans,
especially girls, and seeking medical interventions,
and getting them with virtually no safeguarding,
no gatekeeping, that there's something
that has gone terribly wrong there.
But these clinicians or these activists will say,
but what about the true transgender kids,
for those who really need it?
There's no such thing as those who really need it.
You have to be able to establish that
with evidence and reasoning, and that hasn't been done.
So if you look even at the Dutch protocol,
which is supposed to be the conservative approach here,
the Dutch protocol would automatically exclude
the majority of girls who are today presenting
for medical transition.
Even if you do it according to the Dutch protocol,
the Dutch protocol lacks credible evidence.
The papers that launched this experiment
have been critiqued ruthlessly
in the peer-reviewed medical literature.
I highly recommend that people read one paper in particular
called The Myth of Reliable Research.
It's a fascinating peer-reviewed article
showing the high risk of bias,
the huge methodological problems
that went into the original Dutch experiment.
So again, looking at this
from a clinical outcomes perspective,
or kind of a clinical reasoning perspective,
there's no evidence that any kid benefits from this,
or that gender clinicians can reliably pick out any kid
who will likely grow up to have this lifelong,
agonizing suffering.
There are some kids who are going to grow up
and experience distress
that they associate with their body.
That's true.
But what does it even mean to say
that some kids are just trans?
That what, that they were born in the wrong body?
That's absurd metaphysical speak.
When I talk to people about this issue
who are kind of undecided,
the first thing that I ask them to do
is to define what they mean by a transgender child.
And they usually twist themselves into a pretzel
because they don't want to say a child
who has the wrong body.
That's absurd and it's the wrong message to send to kids.
They can't say a child who is going to grow up
to be a transsexual because how would they know?
And so they end up resorting to something like,
well, a kid who knows that he's transgender,
but how does a kid know he is transgender?
What does it mean to know that?
If you don't have conceptual clarity
about the basis of health and disease,
about why it is that you're intervening
in the body of healthy kids,
these are physically healthy kids,
you cannot perform these interventions.
In most cases, again, from the literature
that I've looked at, they will desist over time
if just kind of left, in some ways,
just left to their own devices.
Right, so the literature about pre,
that's the literature on prepubertal children
does show that the vast majority of them desist
and a large number come out as gay.
The theory among the Dutch was,
okay, but for those who cross the threshold into puberty
and their gender, as they called it back then,
the gender identity disorder, the gender confusion,
did not go away.
In fact, it intensified.
These are the candidates for the medical intervention.
But crucially, and I can't emphasize this point enough,
when they said these kids are eligible for puberty blockers,
they thought that puberty blockers
were a completely reversible intervention
that do nothing but buy time for the kid
to figure out whether to proceed with transition.
Meaning, even according to the Dutch,
puberty blockers are a diagnostic tool.
Meaning, even the Dutch don't know that these kids,
didn't know that these kids were likely
to grow up to be transsexual.
They thought it's possible, it's maybe even likely,
but they weren't sure.
And that's why they said puberty blockers
are part of the diagnostic process.
We now know that they're not diagnostic.
They lock in the medical pathway.
They're the first step on a pathway to full transition.
We talked a little bit about what you're hoping
the incoming Trump administration will do.
One is keep this Supreme Court case alive.
If you had a wish list for what you would like to see
this incoming administration do with respect to this issue.
Yeah, I mean, there's more things
that I could possibly list now,
but maybe some highlights would be,
HHS needs to deprogram itself from gender ideology.
It needs to get rid of all the ideological language,
all the directives.
The NIH, for example, needs to stop pumping money,
hundreds of millions of taxpayer dollars into research
whose only purpose is to promote these interventions.
I actually think that instead of shutting off the valve,
NIH should reorient itself and devote money
to studying the harms, which are not studied.
Nobody's studying harms because the gender clinicians
doing the research don't wanna know.
They're only studying benefits
and then they're spinning the results of their studies.
We need evidence on detransition and regret,
which are real and growing phenomena.
I would also like to see the agencies within NIH
responsible for evidence reviews, step it up.
Do the evidence reviews if you need to,
or at least acknowledge the evidence reviews
performed by other countries.
It would be nice to see the Surgeon General
issue a warning about off-label use of puberty blockers.
At the Department of Justice,
I would like to see an immediate stop
to the persecution of whistleblowers,
specifically Dr. Eitan Haim from Texas
who blew the whistle on Texas Children's Hospital.
He's been subject to a ruthless political persecution
by the Biden administration to try to shut him up
and deter other whistleblowers.
That has to stop.
There's a lot of things
that an incoming Trump administration can do
on the executive side alone
to say nothing of what Congress can do
through its powers of investigation, of appropriations,
even legislation, although that's going to be very difficult.
There's a lot that can be done over the next four years.
And so what about on the executive side?
So, you know, the Biden administration
on day one in office issued executive orders
on trans issues and has issued others too.
A good first step would be for President Trump
to just rescind the executive orders
of the Biden administration on this particular issue.
That's easy to do, right?
Stroke of a pen, you can do it.
Stroke of a pen, you can undo it.
So I'm not sure there's a whole lot else
to be done through executive orders
simply because executive orders can be undone
by the next incoming Democratic president
and will be undone
by the next incoming Democratic president.
We need to, we need the federal government
to use its powers to investigate
how the American medical profession went off track here
and what can be done to restore us
to a place of evidence-based ethical medicine.
Well, Lierre Sapir, it's such a pleasure to have had you on.
Thanks so much, Ian.
Thanks for having me.
Thank you for joining Lierre Sapir and me
on this episode of American Thought Leaders.
I'm your host, Jan Jekielek.